Results 141 to 150 of about 82,830 (185)
Substance Use Patterns in Pediatric Solid Organ Transplant Candidates: Impact After Transplant. [PDF]
Pediatr TransplantThomson D +5 more
europepmc +1 more source
Prophylaxis of graft-versus-host-disease: Systematic evidence-based recommendations of the Brazilian association of hematology, hemotherapy, and cell therapy (ABHH) and the Brazilian society of cellular therapy and bone marrow transplantation (SBTMO). [PDF]
Hematol Transfus Cell TherVigorito AC +8 more
europepmc +1 more source
American Journal of Transplantation, 2010 The efficacy and safety of dual-therapy regimens of twice-daily tacrolimus (BID; Prograf) and once-daily tacrolimus (QD; Advagraf) administered with steroids, without antibody induction, were compared in a multicenter, 1:1-randomized, two-arm, parallel ...
D Seehofer, A D Pinna, B -G Ericzon
exaly +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Drugs, 2006
Tacrolimus is a calcineurin inhibitor recently approved in the US and throughout the EU for the prevention of allograft rejection in heart transplant recipients. It is commonly administered orally for long-term immunosuppression. The incidence of mild to severe acute rejection in the first 6 months following heart transplantation was significantly ...
Paul L, McCormack, Gillian M, Keating
+6 more sources
Tacrolimus is a calcineurin inhibitor recently approved in the US and throughout the EU for the prevention of allograft rejection in heart transplant recipients. It is commonly administered orally for long-term immunosuppression. The incidence of mild to severe acute rejection in the first 6 months following heart transplantation was significantly ...
Paul L, McCormack, Gillian M, Keating
+6 more sources
Journal of Cutaneous Medicine and Surgery, 2001
Background: Tacrolimus (FK 506), a metabolite of the fungus Streptomyces tsukubaensis, is an anti-T-cell drug. It acts by inhibiting the production of IL-2, IL-3, IL-4, TNFα, and GM-CSF. More potent and with slightly less secondary effects than cyclosporine, it has been the object of considerable interest ...
Q H, Dé Tran +3 more
openaire +2 more sources
Background: Tacrolimus (FK 506), a metabolite of the fungus Streptomyces tsukubaensis, is an anti-T-cell drug. It acts by inhibiting the production of IL-2, IL-3, IL-4, TNFα, and GM-CSF. More potent and with slightly less secondary effects than cyclosporine, it has been the object of considerable interest ...
Q H, Dé Tran +3 more
openaire +2 more sources
Seminars in Veterinary Medicine and Surgery: Small Animal, 1997
Cyclosporine and tacrolimus are potent immunosuppressant agents that have been used extensively in humans, primarily for prevention of transplant rejection but also for the treatment of autoimmune disorders. Both agents have similar mechanisms of action and pharmacokinetic profiles. However, the expected toxicity of the agents is dissimilar.
openaire +2 more sources
Cyclosporine and tacrolimus are potent immunosuppressant agents that have been used extensively in humans, primarily for prevention of transplant rejection but also for the treatment of autoimmune disorders. Both agents have similar mechanisms of action and pharmacokinetic profiles. However, the expected toxicity of the agents is dissimilar.
openaire +2 more sources